Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Farmers Insurance
Chinese Patent Office
Argus Health
Teva
Colorcon
McKesson
McKinsey
Cantor Fitzgerald

Generated: July 17, 2018

DrugPatentWatch Database Preview

NEOBIOTIC Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Neobiotic patents expire, and what generic alternatives are available?

Neobiotic is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in NEOBIOTIC is neomycin sulfate. There are nineteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the neomycin sulfate profile page.
Summary for NEOBIOTIC
Drug patent expirations by year for NEOBIOTIC
Medical Subject Heading (MeSH) Categories for NEOBIOTIC
Synonyms for NEOBIOTIC
(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]o
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-2-{[(2S,3R,4S,5R)-4-{[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxycyclohe
(2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(2R,3S,4R,5S)-5-{[(1R,2R,3S,5R,6S)-3,5-diamino-2-{[(2R,3R,4R,5S,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-6-hydroxycyclohexyl]oxy}-4-hydroxy-2-(hydroxymethyl)oxolan-3
11013-50-6
11025-81-3
119-04-0
1393-86-8
1404-04-2
1405-10-3 (sulfate (salt))
30384-EP2272825A2
30384-EP2272838A1
30384-EP2277898A2
30384-EP2287165A2
30384-EP2287166A2
30384-EP2292620A2
30384-EP2295401A2
30384-EP2295402A2
30384-EP2298776A1
30384-EP2305662A1
30384-EP2305695A2
30384-EP2305696A2
30384-EP2305697A2
30384-EP2305698A2
30384-EP2311464A1
4-18-00-07476 (Beilstein Handbook Reference)
4BOC774388
6-(2-{(4S,2R,3R,5R)-4-[(5S,6S,2R,3R,4R)-3-amino-6-(aminomethyl)-4,5-dihydroxy( 2H-3,4,5,6-tetrahydropyran-2-yloxy)]-3-hydroxy-5-(hydroxymethyl)oxolan-2-yloxy }(3S,6S,1R,2R,4R)-4,6-diamino-3-hydroxycyc
6-(2-{(4S,2R,3R,5R)-4-[(5S,6S,2R,3R,4R)-3-amino-6-(aminomethyl)-4,5-dihydroxy( 2H-3,4,5,6-tetrahydropyran-2-yloxy)]-3-hydroxy-5-(hydroxymethyl)oxolan-2-yloxy }(3S,6S,1R,2R,4R)-4,6-diamino-3-hydroxycyclohexyloxy)(3S,2R,4R,5R,6
AB00443887
AB00443887-03
AC1L1QVH
Actilin
Actiline
AKOS024284361
AN-49153
AN-5730
Antibiotic 10676
Antibiotic produced by Streptomyces decaris. Neomycin B
Antibiotique
BDBM19
BDG-(1-4)CYY-(5-1)RIB-(3-1)IDG
BDG-(1-4)NEB-(5-1)RIB-(3-1)NED
BPBio1_000326
BRD-K71013094-065-01-2
BRN 0101621
BSPBio_000296
Bycomycin
C01737
C23H46N6O13
C25H50N6O13
Caswell No. 595
CCRIS 5462
CHEBI:7508
CHEMBL184618
CS-6390
D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy
D-Streptamine, O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(O-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1-3)-beta-D-ribofuranosyl-(1-5))-2-deoxy-
D05140
D05JNI
D0RD0N
DB00452
DR003381
DTXSID2023359
EINECS 204-292-2
EINECS 215-766-3
Endomixin
Enterfram
EPA Pesticide Chemical Code 006303
Fradiomycin
Fradiomycin B
Fradiomycinum
Framicetina
Framicetina [INN-Spanish]
Framycetin
Framycetin (INN)
Framycetin [INN:BAN:DCF]
Framycetin sulfate
Framycetine
Framycetine [INN-French]
Framycetinum
Framycetinum [INN-Latin]
Framygen
Fraquinol
GTPL709
HMS2089P15
HSDB 3242
HY-17624
J-004060
Jernadex
KDR Kinase Inhibitor, 3
lohexyloxy)(3S,2R,4R,5R,6R)-5-amino- 2-(aminomethyl)-2H-3,4,5,6-tetrahydropyran-3,4-diol
LS-96091
LS-96095
MolPort-003-938-736
Myacine
Myacyne
Mycifradin
Mycifradin (TN)
Myciguent
NCGC00179612-01
Neo-Fradin
Neo-fradin (TN)
Neo-Rx
Neo-Tab (TN)
Neobrettin
Neolate
Neomas
Neomcin
Neomicina
Neomicina [DCIT]
Neomin
neomycin
Neomycin [INN:BAN]
NEOMYCIN AND POLYMYXIN B SULFATES
NEOMYCIN B
Neomycin B sulfate
Neomycin solution
NEOMYCIN SULFATE
Neomycin sulphate
Neomycin trisulfate salt hydrate
Neomycine
Neomycine [INN-French]
Neomycinum
Neomycinum [INN-Latin]
Nivemycin
NMY
PGBHMTALBVVCIT-VCIWKGPPSA-N
PIMAVECORT
Prestwick3_000158
SC-83646
SCHEMBL3279
Sofra-Tulle (TN)
Soframycin
Soframycin (TN)
Soframycin Ophthalmic
Soframycine
ST075177
tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
Tuttomycin
UNII-4BOC774388
UNII-I16QD7X297 component PGBHMTALBVVCIT-VCIWKGPPSA-N
USAF CB-19
VONAMYCIN
Vonamycin powder V
ZINC71928291

US Patents and Regulatory Information for NEOBIOTIC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer NEOBIOTIC neomycin sulfate TABLET;ORAL 060475-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Merck
Covington
AstraZeneca
Fish and Richardson
Colorcon
Cipla
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.